Subgroup Analyses of the Amyloid PET Substudies From EMERGE and ENGAGE, Phase 3 Clinical Trials Evaluating Aducanumab in Patients With Early Alzheimers Disease (P1-1.Virtual)
NEUROLOGY(2022)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined